Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 18986 for cognitive symptoms in mild cognitive impairment
2004-004327-35Phase 2Completed
- Sponsor
- Servier
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of s18986 in Mild Cognitive Impairment (MCI) (3 arms), sponsored by Servier. Primary endpoint: Verbal episodic memory performance (RAVLT Trial I-V total score). Started Feb 2005; status: completed.
02
Drugs
s18986
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on 2004-004327-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004327-35.